GAZYVARO 1000 mg, concentrate for solution for infusion bottle, 40 ml

Telegram WhatsApp

Link to share

Active ingredients: OBINUTUZUMAB

Commercialized according to BDPMDispensing in France: Prescription only, hospital use

Concentrate for solution for infusionbottle, 40 mlintraveineuse

No current ANSM shortage notice is included

Package details

Original BDPM fields are shown in French.

Official name: GAZYVARO 1000 mg, solution à diluer pour perfusion
Pharmaceutical form: solution à diluer pour perfusion
Route of administration: intraveineuse
Presentation description: 1 flacon(s) en verre de 40 ml
Marketing authorisation holder: ROCHE REGISTRATION (ALLEMAGNE)
Reimbursement according to BDPM: —
Approval for use in healthcare institutions: oui
Commercialization declaration date: 4 Jan 2016
Prescription and dispensing conditions: Prescription only, hospital use
List I: prescription-only medicine
Requires special monitoring during treatment
Prescribed by specialists only
Hospital use only
Original BDPM wording: liste I · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux médecins compétents en maladie du sang · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services NEPHROLOGIE · prescription réservée aux spécialistes et services RHUMATOLOGIE · réservé à l'usage HOSPITALIER
Enhanced ANSM monitoring: No

BDPM identifiers

CIS61042996CIP75870036CIP133400958700361

Composition in BDPM

Composition in BDPM
Component	Amount per unit	Source type
OBINUTUZUMABsolution	1000 mg · un flacon	SA

Information is based on BDPM data and is for reference only. Consult a doctor before use.

Similar medicines

Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.

The current BDPM data does not list similar medicines for this product.